Research - Jerusalem, Jerusalem District, Israel
SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
Outlook
Nginx
WordPress.org
Google Font API
Mobile Friendly